News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medicago, Inc. Announces a $3.5 Million Private Placement



4/23/2013 10:37:16 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

QUEBEC CITY, April 23, 2013 /CNW Telbec/ - Medicago Inc. ("Medicago" or the "Corporation") (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles ("VLPs"), is pleased to announce that it has entered into an agreement to sell to Le Fonds d'investissement RÉA II Fiera Capital Inc., on a private placement basis, 6,250,000 common shares of the Corporation (the "Common Shares") at a price of $0.56 per share for gross proceeds of $3.5 million (the "Offering").

Help employers find you! Check out all the jobs and post your resume.

Read at Canada NewsWire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES